Work taking place in the clean rooms at Vor (Credit: Vor)
Vor Bio opts to keep manufacturing operations in-house for developing stem cell, CAR-T therapies
While it is not uncommon for a biotech to go down the route of having the product manufactured by a contract organization, one small biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
